{"status": "Ok", "redirect_url": "https://www.cellectar.com/investors/news-events/press-releases/detail/390/cellectar-biosciences-reports-positive-12-month-follow-up-data-from-phase-2b-clover-wam-study-demonstrating-durable-responses-and-efficacy-of-iopofosine-i-131-in-rr-waldenstrm-macroglobulinemia", "message": "News view counter 702899 successfully enlarged"}